6533b82efe1ef96bd129284b

RESEARCH PRODUCT

Temozolomide (TMZ) in radio-chemotherapy combined schedule for treatment of newly-diagnosed high-grade gliomas (HGG)

G. CompostoP. MontemaggiG. MortellaroP. GuerrieriSergio RizzoS. RussoDario PiazzaIgnazio Carreca

subject

OncologyCancer Researchmedicine.medical_specialtyScheduleTemozolomideSettore MED/06 - Oncologia Medicabusiness.industryNewly diagnosedSurgerySafety profileOncologyInternal medicinemedicinebusinessmedicine.drugRadio chemotherapy

description

1578 Background: Temozolomide (TMZ) is an oral alkylating agent known to cross the blood-brain barrier with efficacy against HGG and a favourable safety profile compared to conventional chemotherap...

https://doi.org/10.1200/jco.2005.23.16_suppl.1578